Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis.
Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis.
复制标题
DOI：
10.1186/cc11642
复制
发表时间：
2012-09-19
期刊：
影响因子：
--
通讯作者：
Sherwood ER
中科院分区：
文献类型：
--
作者：
Herzig DS;Guo Y;Fang G;Toliver-Kinsky TE;Sherwood ER
In our previous studies we demonstrated that CXC chemokine receptor 3 (CXCR3) participates in the regulation of lymphocyte trafficking during cecal ligation and puncture (CLP)-induced sepsis. In this study, we evaluated the effects of treatment with anti-CXCR3 immunoglobulin (IgG) and antibiotics on outcome during septic shock caused by CLP. C57BL/6J mice were treated with neutralizing IgG against CXCR3 plus Primaxin either 24 hours prior to, 2 hours after or 6 hours after CLP. Control mice received nonspecific IgG plus Primaxin in the same regimen. Survival, core body temperature, bacterial clearance and systemic cytokine production were evaluated. Our results show that treatment with anti-CXCR3 IgG plus Primaxin significantly improved survival when administered 24 hours prior to CLP (50% vs. 10%), 2 hours after CLP (55% vs. 10%) or 6 hours after CLP (55% vs. 25%) compared with mice receiving nonspecific IgG plus Primaxin. Treatment with anti-CXCR3 plus Primaxin 24 hours prior to CLP attenuated hypothermia and IL-6 and macrophage inflammatory protein 2 (MIP-2) production but did not alter bacterial clearance. Treatment with anti-CXCR3 IgG and Primaxin 2 hours after CLP did not improve bacterial clearance and systemic cytokine production compared with mice treated with IgG and Primaxin, whereas 6 hours after CLP the bacterial clearance and IL-6 and MIP-2 concentrations, both in plasma and peritoneal lavage fluid, were significantly improved in mice receiving anti-CXCR3 IgG and Primaxin compared with mice that only received nonspecific IgG and Primaxin. The results from this study indicate that neutralization of CXCR3 prior to, 2 hours after or 6 hours after the initiation of CLP-induced septic shock improves survival and attenuates CLP-induced inflammation and physiologic dysfunction.
登录
查看更多内容
影响因子：
4.6
作者：
Kivisäkk, P;Trebst, C;Ransohoff, RM
通讯作者：
Ransohoff, RM
DOI：
10.2174/187153007780832109
发表时间：
2007-06-01
影响因子：
1.9
作者：
Singh, Udai P.;Venkataraman, Chandrasekar;Lillard, James W., Jr.
通讯作者：
Lillard, James W., Jr.
DOI：
10.1084/jem.187.12.2009
发表时间：
1998-06-15
期刊：
The Journal of experimental medicine
影响因子：
--
作者：
Cole KE;Strick CA;Paradis TJ;Ogborne KT;Loetscher M;Gladue RP;Lin W;Boyd JG;Moser B;Wood DE;Sahagan BG;Neote K
通讯作者：
Neote K
影响因子：
3.8
作者：
Baker, MS;Chen, XJ;Kaufman, DB
通讯作者：
Kaufman, DB
影响因子：
2.7
作者：
Gu, Dongsheng;Chen, Zhenping;Yang, Renchi
通讯作者：
Yang, Renchi